Conversely, acetylcholinesterase (AChE; E.C. 3.1.1.7) has therapeutic efficacy in AD by improving cholinergic transmission, which increases synaptic acetylcholine (ACh) levels in the cerebral cortex of patients with AD [10]. The gene discussed is ACHE; the disease is Alzheimer disease.